Lara Meisner - Oct 1, 2021 Form 3 Insider Report for Viridian Therapeutics, Inc.\DE (VRDN)

Role: General Counsel and Secretary
Signature: /s/ Kristian Humer, Attorney-in-Fact for Lara Meisner
Stock symbol: VRDN
Transactions as of: Oct 1, 2021
Transactions value $: $0
Form type: 3
Date filed: 10/4/2021, 06:38 PM
Next filing: Feb 3, 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	VRDN	Stock Option (Right to Buy)							Oct 1, 2021	Common Stock	79.5K	$23.03	Direct	F1
holding	VRDN	Stock Option (Right to Buy)							Oct 1, 2021	Common Stock	30K	$14.00	Direct	F2

Showing 1 to 2 of 2 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vests 25% on December 2, 2021 and then in equal monthly installments over the following 3 years, subject to the Reporting Person's continued service to Issuer through each vesting date.
F2	The option vests 25% on September 22, 2022 and then in equal monthly installments over the following 3 years, subject to the Reporting Person's continued service to Issuer through each vesting date.

Remarks:

Exhibit 24 - Power of Attorney